OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

NOVARTIS N/  CH0012005267  /

SIX Swiss Exchange
5/21/2025  1:18:56 PM Chg. -0.10 Volume Bid1:19:18 PM Ask1:19:18 PM Market Capitalization Dividend Y. P/E Ratio
93.19CHF -0.11% 739,377
Turnover: 68.8 mill.		 93.19Bid Size: 293 93.20Ask Size: 242 182.8 bill.CHF - -
GlobeNewswire 5/8 Monte Rosa Therapeutics Announces First Quarter 2025 Financial Results and Business Updates
GlobeNewswire 5/1 Gene Therapy Momentum Builds Among Hematologists in Sickle Cell Disease Management Despite Ongoing A...
TeleTrader 4/30 Novartis to buy Regulus in deal worth up to $1.7B
TeleTrader 4/29 Novartis EPS up 40% to $1.83 in Q1
TeleTrader 4/23 Novartis, Sanofi urge EU to raise prices, warn of industry decline
TeleTrader 4/9 Pharma stocks drop in Europe amid Trump tariff plans
GlobeNewswire 4/2 Grove AI Welcomes Former Novartis, UCB, and Google Executives to Company Advisory Board
GlobeNewswire 3/18 Fabhalta Shakes Up the PNH Market in 15 Months as Soliris, Ultomiris, and Empaveli Compete and Voyde...
GlobeNewswire 3/13 Novartis Pharmaceuticals and Folia Health Partner on Innovative App-Based Study to Assess Real-World...
GlobeNewswire 2/13 Early Launch Metrics Indicate UCB’s Bimzelx (bimekizumab) Poised to Disrupt the U.S. Psoriatic Arthr...
TeleTrader 2/11 Novartis to buy Anthos Therapeutics for up to $3.1B
TeleTrader 1/31 Novartis' Q4 net sales surge 15% to $13.15 billion
TeleTrader 10/29/2024 Novartis' Q2 EPS surge by 116% to $1.58
GlobeNewswire 7/30/2024 Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update
TeleTrader 7/18/2024 Novartis Q2 EPS up 47% to $1.60
GlobeNewswire 7/8/2024 Lexicon Board of Directors Appoints Mike Exton, Ph.D. as New Chief Executive Officer and Director
GlobeNewswire 6/26/2024 As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Co...
GlobeNewswire 6/13/2024 Novartis' Fabhalta Shows Promise in Addressing Critical Gaps in C3 Glomerulopathy Treatment
GlobeNewswire 5/29/2024 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
GlobeNewswire 5/13/2024 Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
TeleTrader 5/2/2024 Novartis to acquire Mariana Oncology for $1.7B
TeleTrader 4/23/2024 Novartis up 5% on upbeat guidance, earnings
TeleTrader 4/23/2024 Novartis EPS up 28% to $1.31 in Q1
GlobeNewswire 4/16/2024 Novartis’ Intravenous Formulation of Cosentyx Impacting Prescriber Preferences in Psoriatic Arthriti...
GlobeNewswire 4/11/2024 Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Develo...